SPP1 and neoplasm: Ablating Kindlin2 expression using CRISPR/Cas9 technology inhibited invasion and migration of tumor cells without affecting their proliferation rate (109); (III) Osteopontin (OPN) glycophosphoprotein in tumor cells increases the recruitment of M2 macrophages.